Paper24487571
Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).
Harding CO and 5 others. J Inherit Metab Dis, 2014. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU). Papers, record 24487571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24487571
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Chemistry | Major topic |
| Cyclohexanones | Major topic |
| Dopamine | Major topic |
| Enzyme Inhibitors | Major topic |
| Nitrobenzoates | Major topic |
| Phenylketonurias | Major topic |
| Tyrosine | Major topic |
| Amino Acids | |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Neurotransmitter Agents |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK048252 | NIDDK NIH HHS | United States | R01DK048252 | PubMed and NIH | NIH RePORTER |
| R01 NS080866 | NINDS NIH HHS | United States | R01NS080866 | PubMed and NIH | NIH RePORTER |
| R01DK059371 | NIH | NIH RePORTER |
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16988900 | Large neutral amino acids in the treatment of phenylketonuria (PKU). | J Inherit Metab Dis | 2006 | https://conductscience.org/library/papers/16988900 | PubMed |
| 2 | 3700406 | Phenylalanine transport at the human blood-brain barrier. Studies with isolated human brain capillaries. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3700406 | PubMed |
| 3 | 22976763 | Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice. | J Inherit Metab Dis | 2013 | https://conductscience.org/library/papers/22976763 | PubMed |
| 4 | 2308957 | Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2308957 | PubMed |
| 6 | 15148857 | Blood phenylalanine control in adolescents with phenylketonuria. | Int J Adolesc Med Health | 2004 | https://conductscience.org/library/papers/15148857 | PubMed |
| 7 | 12499868 | Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria. | Neuroreport | 2002 | https://conductscience.org/library/papers/12499868 | PubMed |
| 8 | 9726963 | Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). | J Biol Chem | 1998 | https://conductscience.org/library/papers/9726963 | PubMed |
| 9 | 7252655 | Unsuccessful treatment of phenylketonuria with tyrosine. | J Pediatr | 1981 | https://conductscience.org/library/papers/7252655 | PubMed |
| 10 | 2463918 | Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine. | Eur J Pediatr | 1988 | https://conductscience.org/library/papers/2463918 | PubMed |
| 11 | 18498375 | Progress toward cell-directed therapy for phenylketonuria. | Clin Genet | 2008 | https://conductscience.org/library/papers/18498375 | PubMed |
| 12 | 1968962 | Enhancement of dopamine release in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin. | J Neurochem | 1990 | https://conductscience.org/library/papers/1968962 | PubMed |
| 13 | 1383656 | Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. | Lancet | 1992 | https://conductscience.org/library/papers/1383656 | PubMed |
| 14 | 2442957 | Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. | Acta Paediatr Scand | 1987 | https://conductscience.org/library/papers/2442957 | PubMed |
| 15 | 10817622 | Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria. | Neuroreport | 2000 | https://conductscience.org/library/papers/10817622 | PubMed |
| 16 | 9797873 | Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle. | Gene Ther | 1998 | https://conductscience.org/library/papers/9797873 | PubMed |
| 17 | 20624808 | Challenges and pitfalls in the management of phenylketonuria. | Pediatrics | 2010 | https://conductscience.org/library/papers/20624808 | PubMed |
| 18 | 20123477 | Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. | Mol Genet Metab | 2010 | https://conductscience.org/library/papers/20123477 | PubMed |
| 19 | 20123466 | Executive function in early-treated phenylketonuria: profile and underlying mechanisms. | Mol Genet Metab | 2010 | https://conductscience.org/library/papers/20123466 | PubMed |
| 21 | 17594394 | Executive functioning in children and adolescents with phenylketonuria. | Clin Genet | 2007 | https://conductscience.org/library/papers/17594394 | PubMed |
| 22 | 1985428 | Intellectual development in 12-year-old children treated for phenylketonuria. | Am J Dis Child | 1991 | https://conductscience.org/library/papers/1985428 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42894462 | Psychometric validation of the NIH Toolbox for use with individuals with phenylketonuria: Evidence from the PHEFREE consortium longitudinal study. | J Int Neuropsychol Soc | 2026 | https://conductscience.org/library/papers/42894462 | PubMed |
| 42280454 | Exploring Subpopulations for Epidemiological Precision Nutrition Research: The Example of Phenylalanine Hydroxylase (PAH) Genetic Variation. | Nutrients | 2026 | https://conductscience.org/library/papers/42280454 | PubMed |
| 40076251 | Small Phenolic Metabolites at the Nexus of Nutrient Transport and Energy Metabolism. | Molecules | 2025 | https://conductscience.org/library/papers/40076251 | PubMed |
| 38666888 | Dissecting Holistic Metabolic Acclimatization of Mucor circinelloides WJ11 Defective in Carotenoid Biosynthesis. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/38666888 | PubMed |
| 35736410 | Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria. | Metabolites | 2022 | https://conductscience.org/library/papers/35736410 | PubMed |
| 35339387 | Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice. | Mol Genet Metab | 2022 | https://conductscience.org/library/papers/35339387 | PubMed |
| 35163145 | A Review of Sensors and Biosensors Modified with Conducting Polymers and Molecularly Imprinted Polymers Used in Electrochemical Detection of Amino Acids: Phenylalanine, Tyrosine, and Tryptophan. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163145 | PubMed |
| 35015767 | The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. | PLoS One | 2022 | https://conductscience.org/library/papers/35015767 | PubMed |
| 34578949 | Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective Study. | Nutrients | 2021 | https://conductscience.org/library/papers/34578949 | PubMed |
| 34017006 | Phenylketonuria. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/34017006 | PubMed |
| 33523197 | Substrate reduction therapy for inborn errors of metabolism. | Emerg Top Life Sci | 2019 | https://conductscience.org/library/papers/33523197 | PubMed |
| 33493163 | Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing. | PLoS One | 2021 | https://conductscience.org/library/papers/33493163 | PubMed |
| 32253938 | Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines. | Hum Gene Ther | 2020 | https://conductscience.org/library/papers/32253938 | PubMed |
| 31993977 | Metabolic and catecholamine response to sympathetic stimulation in early-treated adult male patients with phenylketonuria. | Hormones (Athens) | 2020 | https://conductscience.org/library/papers/31993977 | PubMed |
| 31667718 | Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1. | Paediatr Drugs | 2019 | https://conductscience.org/library/papers/31667718 | PubMed |
| 31623189 | Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice. | Nutrients | 2019 | https://conductscience.org/library/papers/31623189 | PubMed |
| 31037385 | Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging. | Metabolomics | 2019 | https://conductscience.org/library/papers/31037385 | PubMed |
| 30038322 | Hippocampal metabolism of amino acids by L-amino acid oxidase is involved in fear learning and memory. | Sci Rep | 2018 | https://conductscience.org/library/papers/30038322 | PubMed |
| 29754208 | Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone. | JIMD Rep | 2018 | https://conductscience.org/library/papers/29754208 | PubMed |
| 29331172 | Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice. | Mol Genet Metab | 2018 | https://conductscience.org/library/papers/29331172 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HPD | 3242 | PubTator's text mining | https://conductscience.org/library/genes/3242 | NCBI Gene |
| PAH | 5053 | PubTator's text mining | https://conductscience.org/library/genes/5053 | NCBI Gene |
| TAT | 6898 | PubTator's text mining | https://conductscience.org/library/genes/6898 | NCBI Gene |
| TYR | 7299 | PubTator's text mining | https://conductscience.org/library/genes/7299 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24487571
GET https://conductscience.org/api/papers/v1/24487571/references?page=2